Abstract
Enoxacin (CI-919) was evaluated for activity against 120 multiply resistant clinical isolates of the family Enterobacteriaceae and Pseudomonas aeruginosa. The MIC of enoxacin for 95% of the strains tested was less than or equal to 2 micrograms/ml. Approximately 90% of the isolates were susceptible to enoxacin, norfloxacin, ceftazidime, moxalactam, cefotaxime, cefoperazone, and amikacin. Marked resistance to the other seven antimicrobial agents tested was observed.
MeSH Terms
Anti-Bacterial Agents/pharmacology
Drug Resistance, Microbial
Enoxacin
Enterobacteriaceae/drug effects
Gram-Negative Bacteria/drug effects
Naphthyridines/pharmacology
Chemicals
Anti-Bacterial Agents
Naphthyridines
Enoxacin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rudrik J T
Cavalieri S J
Britt E M
References (7)
7 references, click to expand
-
Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715).
Antimicrob Agents Chemother. 1983 Feb;23(2):256-60
PMID: 6220671
-
In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid.
Antimicrob Agents Chemother. 1983 May;23(5):641-8
PMID: 6575721
-
In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound.
Antimicrob Agents Chemother. 1983 May;23(5):658-63
PMID: 6223577
-
In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
Antimicrob Agents Chemother. 1983 Nov;24(5):754-63
PMID: 6229216
-
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.
Antimicrob Agents Chemother. 1983 Jul;24(1):54-60
PMID: 6226241
-
In vitro and in vivo antibacterial activity of AT-2266.
Antimicrob Agents Chemother. 1983 Jul;24(1):78-84
PMID: 6226242
-
Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice.
Antimicrob Agents Chemother. 1983 May;23(5):742-9
PMID: 6223579